![Julie Jordan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julie Jordan
Net worth: 10 608 $ as of 2024-05-30
Julie Jordan active positions
Companies | Position | Start | End |
---|
Career history of Julie Jordan
Former positions of Julie Jordan
Companies | Position | Start | End |
---|---|---|---|
Cerevel Therapeutics, Inc.
![]() Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Corporate Officer/Principal | - | - |
AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
Q32 BIO INC. | Chief Operating Officer | 2022-01-31 | 2023-03-08 |
Chief Tech/Sci/R&D Officer | 2021-04-30 | - |
Training of Julie Jordan
Harvard College | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Statistics
International
United States | 6 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Homology Medicines, Inc.
![]() Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Cerevel Therapeutics, Inc.
![]() Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Health Technology |
Avanir Pharmaceuticals, Inc.
![]() Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
- Stock Market
- Insiders
- Julie Jordan
- Experience